A promising diagnostic tool for toxoplasmic encephalitis: Tachyzoite/bradyzoite stage-specific RT-PCR

International Journal of Infectious Diseases

Volumn 16, Issue 4, 2012, Pages

  Sukthana, Yaowalark ^a   Mahittikorn, Aongart ^a   Wickert, Hannes ^b,c   Tansuphaswasdikul, Somsit ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Medical Laboratories Dr Staber and Partner   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d Bamrasnaradura Infectious Disease Institute   (Thailand)

Author keywords

AIDS patients; Duplex RT PCR; Sensitivity and specificity; Stage conversion; Tachyzoite bradyzoite; Toxoplasmic encephalitis

Indexed keywords

BAG 1 PROTEIN; PROTEIN SAG 1; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; BRADYZOITE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DUPLEX REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ENCEPHALITIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROTOZOAL GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STANDARD; TACHYZOITE; TOXOPLASMIC ENCEPHALITIS;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ENCEPHALITIS; FEMALE; GENES, PROTOZOAN; HUMANS; LIFE CYCLE STAGES; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MULTIPLEX POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; TOXOPLASMA; TOXOPLASMOSIS, CEREBRAL; YOUNG ADULT;

EID: 84858279174     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.12.009     Document Type: Article

References (24)

1. Sacktor N., Lyles R.H., Skolasky R., Kleeberger C., Selnes O.A., Miller E.N., et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001, 56:257-260.
2. Jones J.L., Hanson D.L., Chu S.Y., Ciesielski C.A., Kaplan J.E., Ward J.W., et al. Toxoplasmic encephalitis in HIV-infected persons: risk factors and trends. AIDS 1996, 10:1393-1399.
3. Bossi P., Caumes E., Astagneau P., Li T.S., Paris L., Mengual X., et al. [Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994] (in French). Rev Med Interne 1998, 19:313-317.
4. Furrer H., Egger M., Opravil M., Bernasconi E., Hirschel B., Battegay M., et al. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. N Engl J Med 1999, 340:1301-1306.
5. Abgrall S., Rabaud C., Costagliola D. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Clin Infect Dis 2001, 33:1747-1755.
6. Luft B.J., Remington J.S. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992, 15:211-222.
7. Richards F.O., Kovacs J.A., Luft B.J. Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clin Infect Dis 1995, 21(Suppl 1):S49-S56.
8. Sukthana Y. Toxoplasmosis: beyond animals to humans. Trends Parasitol 2006, 22:137-142.
9. Ajzenberg D., Yera H., Marty P., Paris L., Dalle F., Menotti J., et al. Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings. J Infect Dis 2009, 199:1155-1167.
10. Kaplan J.E., Benson C., Holmes K.H., Brooks J.T., Pau A., Masur H. Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009, 58(RR-4):1-198.
11. Mariuz P., Steigbigel R.T. Toxoplasma infection in HIV-infected patients. Toxoplasmosis: a comprehensive clinical guide. 2001, 147-177. Cambridge University Press, Cambridge. D.H. Joynson, T.G. Wreghitt (Eds.).
12. Lee G.T., Antelo F., Mlikotic A.A. Best cases from the AFIP: cerebral toxoplasmosis. Radiographics 2009, 29:1200-1205.
13. Legrand L., Catherine L., Brivet F., Musset D. Solitary hypothalamopituitary toxoplasmosis abscess in a patient with AIDS. AJNR Am J Neuroradiol 2011, 32:E105-E106.
14. Mahittikorn A., Wickert H., Sukthana Y. Toxoplasma gondii: simple duplex RT-PCR assay for detecting SAG1 and BAG1 genes during stage conversion in immunosuppressed mice. Exp Parasitol 2010, 124:225-231.
15. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
16. Weenink J.J., Weenink A.G., Geerlings S.E., van Gool T., Bemelman F.J. Severe cerebral Toxoplasma infection cannot be excluded by a normal CT scan. Neth J Med 2009, 67:150-152.
17. Collazos J. Opportunistic infections of the CNS in patients with AIDS: diagnosis and management. CNS Drugs 2003, 17:869-887.
18. Odaert H., Soête M., Fortier B., Camus D., Dubremetz J.F. Stage conversion of Toxoplasma gondii in mouse brain during infection and immunodepression. Parasitol Res 1996, 82:28-31.
19. Martin-Blondel G., Alvarez M., Delobel P., Uro-Coste E., Cuzin L., Cuvinciuc V., et al. Toxoplasmic encephalitis IRIS in HIV-infected patients: a case series and review of the literature. J Neurol Neurosurg Psychiatry 2011, 82:691-693.
20. Béraud G., Pierre-François S., Foltzer A., Abel S., Liautaud B., Smadja D., et al. Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994-2006. Am J Trop Med Hyg 2009, 80:583-587.
21. Foudrinier F., Aubert D., Puygauthier-Toubas D., Rouger C., Beguinot I., Halbout P., et al. Detection of Toxoplasma gondii in immunodeficient subjects by gene amplification: influence of therapeutics. Scand J Infect Dis 1996, 28:383-386.
22. Bastien P. Molecular diagnosis of toxoplasmosis. Trans R Soc Trop Med Hyg 2002, 96(Suppl 1):S205-S215.
23. Colombo F.A., Vidal J.E., Penalva de Oliveira A.C., Hernandez A.V., Bonasser-Filho F., Nogueira R.S., et al. Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples. J Clin Microbiol 2005, 43:5044-5047.
24. Reding M.T., Hibbs J.R., Morrison V.A., Swaim W.R., Filice G.A. Diagnosis and outcome of 100 consecutive patients with extreme granulocytic leukocytosis. Am J Med 1998, 104:12-16.